1. Exploring miR-9 Involvement in Ciona intestinalis Neural Development Using Peptide Nucleic Acids
   Silvia Mercurio et al, 2020, IJMS CrossRef
2. Synthesis and Biological Evaluation of New Antitubulin Agents Containing 2-(3′,4′,5′-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold
   Romeo Romagnoli et al, 2020, Molecules CrossRef
3. microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics
   Marta Gomarasca et al, 2020, IJMS CrossRef
4. Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation.
   Yanming Liu et al, 2020, PeerJ CrossRef
5. Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment
   Jun Wei et al, 2021, Front. Oncol. CrossRef
6. Competitive Endogenous RNA Landscape in Epstein-Barr Virus Associated Nasopharyngeal Carcinoma
   Xiandong Lin et al, 2021, Front. Cell Dev. Biol. CrossRef
7. Treatment of Human Glioblastoma U251 Cells with Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis.
   Jessica Gasparello et al, 2022, Molecules CrossRef
8. Non-coding RNAs Enhance the Apoptosis Efficacy of Therapeutic Agents Used for the Treatment of Glioblastoma Multiform
   Shokoofeh Ghaemi et al, 2022, Journal of Drug Targeting CrossRef
9. The Role of microRNAs in Multidrug Resistance of Glioblastoma
   Parvaneh Mahinfar et al, 2022, Cancers CrossRef
10. Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics
    Sai Pallavi Pradeep et al, 2023, RNA CrossRef
11. Valproic acid regulates the miR-155/Jarid2 axis by affecting miR-155 promoter methylation in glioma
    Ruixuan Wang et al, 2023, ABBS CrossRef